# PBE holdings: all 32 positions

> All 32 PBE holdings with weights, as of Oct 13, 2026. The top 3 are ILMN 6.26%, NTRA 6.10% and BIIB 5.39%. Download the full list as a CSV.

Data as of Oct 13, 2026. Rebuilt every trading night.

PBE held 32 positions as of Oct 13, 2026. Illumina Inc is the largest at 6.26%; the top 10 are 49.5% of the fund.

Source: Invesco (https://dng-api.invesco.com/cache/v1/accounts/en_US/shareclasses/46137V787/holdings/fund?idType=cusip&productType=ETF).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Illumina Inc | ILMN | 6.26% |
| 2 | Natera Inc | NTRA | 6.10% |
| 3 | Biogen Inc | BIIB | 5.39% |
| 4 | Gilead Sciences Inc | GILD | 5.17% |
| 5 | Amgen Inc | AMGN | 4.85% |
| 6 | Royalty Pharma PLC | RPRX | 4.73% |
| 7 | Regeneron Pharmaceuticals Inc | REGN | 4.69% |
| 8 | Vertex Pharmaceuticals Inc | VRTX | 4.56% |
| 9 | Moderna Inc | MRNA | 3.86% |
| 10 | Novavax Inc | NVAX | 3.85% |
| 11 | Exelixis Inc | EXEL | 2.97% |
| 12 | United Therapeutics Corp | UTHR | 2.97% |
| 13 | Qiagen N.V. | QGEN | 2.95% |
| 14 | Halozyme Therapeutics Inc | HALO | 2.84% |
| 15 | TG Therapeutics Inc | TGTX | 2.78% |
| 16 | Veracyte Inc | VCYT | 2.77% |
| 17 | Repligen Corp | RGEN | 2.74% |
| 18 | Vericel Corp | VCEL | 2.64% |
| 19 | Protagonist Therapeutics Inc | PTGX | 2.61% |
| 20 | Neurocrine Biosciences Inc | NBIX | 2.50% |
| 21 | Sarepta Therapeutics Inc | SRPT | 2.47% |
| 22 | Legend Biotech Corp | LEGN | 2.38% |
| 23 | Incyte Corp | INCY | 2.37% |
| 24 | Ardelyx Inc | ARDX | 2.34% |
| 25 | BioMarin Pharmaceutical Inc | BMRN | 2.33% |
| | Cash & Equivalents | | <0.01% |
| | Cash and other net assets | | <0.01% |

The largest 25 of 32 positions are shown. All of them: https://etfiq.com/funds/pbe/holdings/pbe-holdings.csv (CSV) or https://etfiq.com/data/books/pbe.json (JSON).

Fund page: https://etfiq.com/funds/pbe

Cite: ETFIQ, Holdings of PBE, data as of Oct 13, 2026. https://etfiq.com/funds/pbe/holdings/